Tocilizumab for Treatment of Severe or Life-Threatening Chimeric Antigen Receptor T Cell-Induced Cytokine Release Syndrome—FDA Approval Summary

Biology of Blood and Marrow Transplantation - Netherlands

doi 10.1016/j.bbmt.2017.12.104